Cisplatin, the Timeless Molecule

Cisplatin was the first metal-based anticancer drug introduced into clinical use. It is a “small” molecule, but it represented a very “big” discovery. Since it was introduced on the market, it has not been withdrawn, despite being not free of side effects, owing to its peculiarity of being highly ef...

Full description

Saved in:
Bibliographic Details
Main Authors: Annaluisa Mariconda, Jessica Ceramella, Alessia Catalano, Carmela Saturnino, Maria Stefania Sinicropi, Pasquale Longo
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Inorganics
Subjects:
Online Access:https://www.mdpi.com/2304-6740/13/7/246
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839615872060096512
author Annaluisa Mariconda
Jessica Ceramella
Alessia Catalano
Carmela Saturnino
Maria Stefania Sinicropi
Pasquale Longo
author_facet Annaluisa Mariconda
Jessica Ceramella
Alessia Catalano
Carmela Saturnino
Maria Stefania Sinicropi
Pasquale Longo
author_sort Annaluisa Mariconda
collection DOAJ
description Cisplatin was the first metal-based anticancer drug introduced into clinical use. It is a “small” molecule, but it represented a very “big” discovery. Since it was introduced on the market, it has not been withdrawn, despite being not free of side effects, owing to its peculiarity of being highly effective in the treatment of cancer. Anticancer activity of the platinum-based complexes was discovered with this molecule; since then, several other platinum-based drugs have been developed and tested in preclinical studies against cancer cells; however, only a few of them reached clinical trials, and their side effects are not much less than cisplatin. Despite the constraints of drug resistance and side effects, chemotherapy remains a fundamental strategy in cancer treatment. Nowadays, cisplatin remains one of the most-used anticancer agents in treating lung, colon, ovary, testicles, bladder, cervix, and many more cancers, although cisplatin resistance represents a major hurdle in cancer treatment. Will there ever be another drug that can overcome the side effects of cisplatin but at the same time be able to block tumors as does cisplatin?
format Article
id doaj-art-f9eb6386cf8b43a0b84c6ffb5ed1e3fe
institution Matheson Library
issn 2304-6740
language English
publishDate 2025-07-01
publisher MDPI AG
record_format Article
series Inorganics
spelling doaj-art-f9eb6386cf8b43a0b84c6ffb5ed1e3fe2025-07-25T13:25:28ZengMDPI AGInorganics2304-67402025-07-0113724610.3390/inorganics13070246Cisplatin, the Timeless MoleculeAnnaluisa Mariconda0Jessica Ceramella1Alessia Catalano2Carmela Saturnino3Maria Stefania Sinicropi4Pasquale Longo5Department of Basic and Applied Sciences, University of Basilicata, Via dell’Ateneo Lucano, 10, 85100 Potenza, ItalyDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via Pietro Bucci, 87036 Arcavacata di Rende, ItalyDepartment of Pharmacy-Drug Sciences, University of Bari “Aldo Moro”, Via Orabona, 4, 70126 Bari, ItalyDepartment of Health Sciences, University of Basilicata, Via dell’Ateneo Lucano, 10, 85100 Potenza, ItalyDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via Pietro Bucci, 87036 Arcavacata di Rende, ItalyDepartment of Chemistry and Biology “A. Zambelli”, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, ItalyCisplatin was the first metal-based anticancer drug introduced into clinical use. It is a “small” molecule, but it represented a very “big” discovery. Since it was introduced on the market, it has not been withdrawn, despite being not free of side effects, owing to its peculiarity of being highly effective in the treatment of cancer. Anticancer activity of the platinum-based complexes was discovered with this molecule; since then, several other platinum-based drugs have been developed and tested in preclinical studies against cancer cells; however, only a few of them reached clinical trials, and their side effects are not much less than cisplatin. Despite the constraints of drug resistance and side effects, chemotherapy remains a fundamental strategy in cancer treatment. Nowadays, cisplatin remains one of the most-used anticancer agents in treating lung, colon, ovary, testicles, bladder, cervix, and many more cancers, although cisplatin resistance represents a major hurdle in cancer treatment. Will there ever be another drug that can overcome the side effects of cisplatin but at the same time be able to block tumors as does cisplatin?https://www.mdpi.com/2304-6740/13/7/246cisplatinplatinum complexesprecious metalsanticancer drugs
spellingShingle Annaluisa Mariconda
Jessica Ceramella
Alessia Catalano
Carmela Saturnino
Maria Stefania Sinicropi
Pasquale Longo
Cisplatin, the Timeless Molecule
Inorganics
cisplatin
platinum complexes
precious metals
anticancer drugs
title Cisplatin, the Timeless Molecule
title_full Cisplatin, the Timeless Molecule
title_fullStr Cisplatin, the Timeless Molecule
title_full_unstemmed Cisplatin, the Timeless Molecule
title_short Cisplatin, the Timeless Molecule
title_sort cisplatin the timeless molecule
topic cisplatin
platinum complexes
precious metals
anticancer drugs
url https://www.mdpi.com/2304-6740/13/7/246
work_keys_str_mv AT annaluisamariconda cisplatinthetimelessmolecule
AT jessicaceramella cisplatinthetimelessmolecule
AT alessiacatalano cisplatinthetimelessmolecule
AT carmelasaturnino cisplatinthetimelessmolecule
AT mariastefaniasinicropi cisplatinthetimelessmolecule
AT pasqualelongo cisplatinthetimelessmolecule